LIMITED STAGE SMALL-CELL LUNG CANCER
Clinical trials for LIMITED STAGE SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED STAGE SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED STAGE SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bugs join fight against lung cancer in new trial
Disease control Recruiting nowThis study tests whether adding probiotics (healthy bacteria) to a stronger type of radiation, chemotherapy, and an immunotherapy drug can help people with limited-stage small cell lung cancer live longer without the cancer growing. About 60 adults aged 18-80 will take part. The …
Matched conditions: LIMITED STAGE SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 17, 2026 07:04 UTC
-
New hope for lung cancer: drug duo targets tough-to-treat SCLC
Disease control Recruiting nowThis study tests two immunotherapy drugs (monalizumab and durvalumab) with or without chemotherapy for small cell lung cancer (SCLC). It includes 84 adults with either extensive-stage or limited-stage SCLC. The goal is to see if the combination helps control the cancer longer and…
Matched conditions: LIMITED STAGE SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Hirva Mamdani • Aim: Disease control
Last updated May 17, 2026 06:52 UTC
-
New lung cancer drug combo aims to extend survival in early-stage disease
Disease control Recruiting nowThis study compares a new drug combination (BMS-986489) against the standard drug durvalumab as follow-up treatment after chemoradiation for people with limited-stage small cell lung cancer. About 250 adults will take part. The goal is to see if the new combo helps people live lo…
Matched conditions: LIMITED STAGE SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: SCRI Development Innovations, LLC • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New hope for lung cancer patients: maintenance drug after Chemo-Radiation
Disease control Recruiting nowThis study tests a drug called tarlatamab as a maintenance therapy for people with limited-stage small-cell lung cancer who cannot receive standard concurrent chemo-radiotherapy. After completing sequential chemo-radiation or chemotherapy alone, participants whose cancer has not …
Matched conditions: LIMITED STAGE SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
New hope for lung cancer: drug may keep disease in check after standard therapy
Disease control Recruiting nowThis study looks at whether the drug durvalumab can help control limited-stage small-cell lung cancer after initial chemoradiation. About 200 adults in China whose cancer did not worsen after standard treatment will receive durvalumab. Researchers will track how long the cancer s…
Matched conditions: LIMITED STAGE SMALL-CELL LUNG CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 15, 2026 11:55 UTC